Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
COVID-19, HIV vaccines, cure news and long-acting injectables stood out among the top HIV treatment stories of the year.
A survey of 6,500 HIV vaccine trial participants found that the good feeling involved with being altruistic was a major benefit.
Social media posts that make misleading comparisons undermine the science behind the COVID-19 vaccine.
Fosters interdisciplinary knowledge-exchange on HIV vaccines, microbicides, PrEP, treatment as prevention and biomedical interventions.
New mRNA vaccine approach protects monkeys from HIV-like virus.
Researchers believe that in addition to producing antibodies against the virus, vaccines must also give rise to a cellular immune response.
The NIH-funded network has launched its first clinical trial in response to the new pandemic.
Large trial of HIV vaccine finds it does not prevent HIV
Monday, May 18 is HIV Vaccine Advocacy Day. Support science. Not sound bites.
The new coronavirus crisis has upended the clinical trials process around the world.
Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.
The International AIDS Conference takes place July 6 to 10 in San Francisco and Oakland.
Conducted in South Africa, it’s one of three major late-stage trials.
An $80,000 grant from The Campbell Foundation will help scientist Natalia Freund continue her HIV vaccine studies.
Only HIV vax to show any efficacy prompted strong immune response in new study
They’re the 2019 recipients of amfAR’s Mathilde Krim Fellowship in Basic Biomedical Research.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.